Sally Bennett

Dr Sally Bennett has a career spanning medicine, equity & capital markets and investment management. She brings over 20 years industry experience in senior roles across the financial sector within the life science and biopharmaceutical space.

She is currently a senior member of the private investment team (part-time) at HealthCor, a large healthcare focused US based investment firm where she co-leads the funds more recent move into private investing. Prior to HealthCor, she spent ten years as a senior financial analyst at ING Financial Markets and then at Piper Jaffray.

Dr Bennett serves as an Independent Non-Executive Director at BerGenBio, a publicly traded European biopharmaceutical company, where she Chairs the Audit Committee and is also an Advisory Board member of the P4 Precision Medicine Accelerator Programme in the UK.